Related Experiment Video

Updated: Jun 24, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy

Alexander Kulik1, Vincent Chan, Marc Ruel

  • 1Cardiovascular Surgery Fellow Missouri Baptist Medical Center St Louis, Missouri, USA.

Expert Opinion on Drug Safety
|March 25, 2009
PubMed

Insights

For coronary artery bypass graft surgery (CABG), stop aspirin 7-10 days and clopidogrel 5 days before. Resume aspirin 48 hours post-surgery to prevent clots and bleeding.

Area of Science:

  • Cardiology
  • Vascular Surgery
  • Pharmacology

Background:

  • Antiplatelet therapy is crucial for coronary artery disease management.
  • Optimal use of antiplatelet agents around coronary artery bypass graft surgery (CABG) remains debated.
  • Key concerns include preoperative safety and postoperative regimens for graft patency and preventing ischemic events.

Purpose of the Study:

  • To systematically review risks and benefits of preoperative aspirin and clopidogrel.
  • To determine optimal aspirin timing and dosage post-CABG.
  • To assess the role of postoperative clopidogrel therapy.

Main Methods:

  • Systematic review of Medline database.
  • Literature search from 1978 to 2008.
  • Analysis of antiplatelet therapy strategies in CABG patients.

Main Results:

  • Aspirin cessation for 7-10 days pre-CABG is suggested, but debated.
  • Clopidogrel should be stopped at least 5 days before CABG to minimize bleeding.
  • Postoperative aspirin (100-325 mg daily, started within 48h) is strongly supported; clopidogrel use is less defined but recommended for acute coronary syndrome patients.

Conclusions:

  • Despite extensive use, perioperative antiplatelet management for CABG needs refinement.
  • Ongoing trials will clarify optimal aspirin and clopidogrel use.
  • Evidence supports aspirin post-CABG, while clopidogrel's role is evolving.
Abstract

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...